HK-listed HUTCHMED jumps on 2024 profit beat
20/03/2025 05:02
** Pharmaceuticals group HUTCHMED (China) 0013.HK jumps 10.7% to HK$26.45, highest since March 7
** Stock set for biggest one-day pct rise since March 13, 2024; third-biggest pct gainer on healthcare index .HSCIH, which is up 0.5%
** Co's 2024 net income attributable came in at $37.73 mln vs $100.78 mln in 2023
** Analysts on avg had forecast loss of $58.57 mln
** Jefferies ("buy") says co's FY24 profitability ahead of guidance
** YTD, stock up 16%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))